MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India.

MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human, reaches a new milestone by starting clinical trials in India, the most populated country in the world and the one with the highest number of cases of this infectious disease.

Please read the press release for more information: Spanish vaccine against TB begins Phase 3.